DSIP and Metformin Interaction
DSIP and Metformin have an interaction requiring monitoring for interaction with 46% confidence. Both DSIP and Metformin enhance GABAergic activity. Combined CNS depression increases risk of excessive sedation, respiratory depression, and impaired coordination. Do not combine with alcohol. These compounds primarily affect different organ systems.
Compound Profiles
DSIP
Delta Sleep-Inducing Peptide | Sleep & Stress Modulator
Modulates multiple neurotransmitter systems including GABA enhancement, NMDA receptor interaction, and endogenous opioid system modulation. Also regulates hypothalamic-pituitary-adrenal axis for stress response.
View full profileMetformin
Biguanide | AMPK Activator & Longevity Research
Metformin exerts its primary effects through activation of AMP-activated protein kinase (AMPK), the cell's master energy sensor. AMPK activation triggers a cascade of downstream metabolic improvements: enhanced glucose uptake in skeletal muscle, suppression of hepatic gluconeogenesis, improved mitochondrial function, and increased fatty acid oxidation.
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take DSIP with Metformin?
Yes, but with caution. Both DSIP and Metformin enhance GABAergic activity. Combined CNS depression increases risk of excessive sedation, respiratory depression, and impaired coordination. Do not combine with alcohol. Regular monitoring is advised.
Is DSIP and Metformin safe together?
Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: gabaergic. Monitor accordingly.
What are the interactions between DSIP and Metformin?
Both DSIP and Metformin enhance GABAergic activity. Combined CNS depression increases risk of excessive sedation, respiratory depression, and impaired coordination. Do not combine with alcohol. This assessment has 46% confidence and is inferred from pharmacological mechanism analysis.
How should I time DSIP and Metformin?
DSIP has a half-life of ~15 minutes (in vitro) and Metformin has a half-life of ~5 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.